Okayama, Japan

Naohiro Oda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Okayama University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naohiro Oda. Retrieved from https://idiyas.com/inventor/naohiro-oda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naohiro Oda: Innovator in Medicinal Composition for Respiratory Diseases

Introduction

Naohiro Oda is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of medicinal compositions, particularly in the treatment of inflammatory respiratory diseases. His innovative approach has the potential to impact the medical community positively.

Latest Patents

Naohiro Oda holds a patent for a medicinal composition aimed at preventing or treating inflammatory respiratory diseases. The patent describes a method that involves administering an effective amount of an RXR agonist as an active ingredient. This method is represented by specific formulas, which detail the components involved in the treatment process.

Career Highlights

Oda is affiliated with Okayama University, where he conducts research and develops his innovative ideas. His work has garnered attention for its potential applications in medical treatments, particularly for respiratory conditions.

Collaborations

Naohiro Oda collaborates with esteemed colleagues such as Arihiko Kanehiro and Utako Fujii. Their combined expertise enhances the research and development efforts in the field of medicinal compositions.

Conclusion

Naohiro Oda's contributions to the field of medicinal compositions demonstrate his commitment to advancing healthcare solutions. His innovative patent reflects a significant step forward in treating inflammatory respiratory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…